| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |